Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Javle

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Acta Oncologica (Stockholm, Sweden)|July 29, 2011
Radiation treatment outcomes for unresectable hepatocellular carcinomaHeath D Skinner, Hadley J Sharp, Ahmed O Kaseb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracilMilind M Javle, Shousong Cao, Farukh A Durrani, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imagingJane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 29, 2006
Management of locoregional stage esophageal cancer: a single center experienceM M Javle, C E Nwogu, K A Donohue, et al.
Annals of Surgical Oncology|June 27, 2023
NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic CholangiocarcinomaShishir K Maithel, Jessica M Keilson, Hop S Tran Cao, et al.
Journal of Gastroenterology and Hepatology|September 21, 2006
Akt expression may predict favorable prognosis in cholangiocarcinomaMilind M Javle, Jihnhee Yu, Thaer Khoury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic CancerJennifer B Goldstein, Li Zhao, Xuemei Wang, et al.
Cancer Investigation|February 25, 2009
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysisMilind M Javle, Gary Yang, Chumy E Nwogu, et al.
Investigational New Drugs|January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancerBassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumorsAlberto A Chiappori, S Gail Eckhardt, Ronald Bukowski, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Acta Oncologica (Stockholm, Sweden)|July 29, 2011
Radiation treatment outcomes for unresectable hepatocellular carcinomaHeath D Skinner, Hadley J Sharp, Ahmed O Kaseb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracilMilind M Javle, Shousong Cao, Farukh A Durrani, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imagingJane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 29, 2006
Management of locoregional stage esophageal cancer: a single center experienceM M Javle, C E Nwogu, K A Donohue, et al.
Annals of Surgical Oncology|June 27, 2023
NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic CholangiocarcinomaShishir K Maithel, Jessica M Keilson, Hop S Tran Cao, et al.
Journal of Gastroenterology and Hepatology|September 21, 2006
Akt expression may predict favorable prognosis in cholangiocarcinomaMilind M Javle, Jihnhee Yu, Thaer Khoury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic CancerJennifer B Goldstein, Li Zhao, Xuemei Wang, et al.
Cancer Investigation|February 25, 2009
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysisMilind M Javle, Gary Yang, Chumy E Nwogu, et al.
Investigational New Drugs|January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancerBassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumorsAlberto A Chiappori, S Gail Eckhardt, Ronald Bukowski, et al.
Pageof 10